Clinical Trials Logo

Clinical Trial Summary

The primary outcome of this study is to investigate whether deep NMB reversed with Sugammadex is superior to moderate NMB reversed with Neostigmine, in terms of overall pain in the first 48 hrs after laparoscopic gynecologic surgery, reversal time from NMB (TOF≄0.9) and direct and indirect costs. Additionally we will also assess: drugs consumption for pain and antiemetics (rescue dose), surgical conditions, hemodynamic and respiratory stability, operation time, anesthesia time, total amount and flow rate of CO2, insufflation time, resolution of post-operative ileus, dry mouth and PONV in the first 48 hours, patient satisfaction


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Curarization, Postoperative Residual
  • Delayed Emergence from Anesthesia

NCT number NCT03519724
Study type Interventional
Source Campus Bio-Medico University
Contact
Status Not yet recruiting
Phase Phase 2
Start date July 30, 2018
Completion date January 30, 2019

See also
  Status Clinical Trial Phase
Completed NCT03585400 - Validation of the REPS Prediction Tool
Not yet recruiting NCT03519633 - Role of Curarization During Anesthesia for Gynecologic Surgical Laparoscopic Procedures Phase 2
Completed NCT04762420 - Sugammadex Dosing: Anaesthesiologist Clinical Perception Versus Quantitative Monitoring